Chamber and committees

We are working closely with Health and Social Care partnerships and COSLA to monitor the costs of the extension of the free personal care policy and this will help to inform future funding allocations.

The Scottish Government will publish its spending plans in due course as part of the Scottish Budget.

Guidance on Free Personal Care was renewed to include the extension of free personal care and this was sent in December 2018 to COSLA, Chief Officers and Chief Finance Officers of Health and Social Care Partnerships, Chief Executives, Chief Finance Officers and Chief Social Work Officers of Local Authorities, Social Work Scotland’s Self-directed Support Practice Forum and the Social Work Scotland Adult Social Care Committee.

https://www.sehd.scot.nhs.uk/publications/cc2018_03.pdf

Together with the First Minister, I officially launched the extension of free personal care at an event at Capability Scotland which received extensive media coverage.

The Scottish Government produced a short Q and A document for the public setting out the key features on the policy which is available on our website.

https://www.gov.scot/publications/free-personal-nursing-care-qa/

I also took part in an interview with the Scottish Commission for Learning Disability to produce video clips setting out how disabled people can access free personal care. These are also available on the Scottish Government website.

https://blogs.gov.scot/health-social-care-integration/2019/03/29/free-personal-care-for-under-65s/

The following table provides the financial allocation by Local Authority in 2019/20 for the extension of Free Personal Care to under 65s.

The Scottish Government funds the NHS Research Scotland Dementia and Neuro-progressive Research Network to support eligibly funded and commercial clinical studies hosted by the NHS in Scotland.

Researchers based in Scotland can also apply for funding to the Chief Scientist Office’s funding committees. Details of these are available from the CSO website https://www.cso.scot.nhs.uk/funding-2/response-mode-funding-schemes/ .

Scotland has a wide range of researchers in this field and our commitment in Programme for Government to establish Scotland's Brain Health Centre - the first of its kind - will help enhance focus on dementia research, including in the area of prevention.

The Scottish Government does not routinely comment on the work of individual researchers.

Advances in dementia research require sustained global effort. Scotland has a wide range of researchers in this field and our commitment in Programme for Government to establish Scotland's Brain Health Centre - the first of its kind - will help enhance focus on dementia research, including in the area of prevention.

We also fund the NHS Research Scotland Dementia and Neuro-progressive Research Network to support eligibly funded and commercial clinical studies hosted by the NHS here.

Researchers can also apply for funding to the Chief Scientist Office’s funding committees. Details of these are available from the CSO website https://www.cso.scot.nhs.uk/funding-2/response-mode-funding-schemes/ .

On behalf of the National Advisory Committee for Chronic Pain (NACCP), the Deputy Chief Medical Officer commissioned Scottish NHS Boards to provide information about the quantity of different healthcare professionals working within specialist pain services across Scotland, as well as qualitative information about recruitment/ retention challenges and succession planning for this workforce group. This work was supported by Officials in the Scottish Government’s Planning and Quality Division.

The subsequent report ’Findings of Scottish Specialist Pain Workforce Study’ was produced by officials across the Health and Social Care Directorate with analytical support.

The Scottish Government committed to publishing the data provided by NHS Boards, which informed the report “Findings of Scottish Specialist Pain Workforce Study early in the New Year and we are on track to meet this commitment.

The NHS in Scotland continues to invest in improving our approach to the dispensing of medicine in hospitals, such as in the use of robotic dispensing systems. The Scottish Government has identified the implementation of Hospital Electronic Prescribing and Medicines Administration (HEPMA) as the priority focus to reduce medication errors and improve patient safety and we expect all NHS Boards to implement HEPMA in the next 3-5 years.

However, it is essential that we consider all emerging digital opportunities to further improve patient safety and medicines reconciliation processes. Whilst automated medicine cabinets are not widely available in Scotland at present the Scottish Government will consider the forthcoming research from the Centre for Medication Safety and Service Quality (CMSSQ) who are conducting an independent academic study into the benefits of cabinet technology within UK hospitals. This research is expected to evaluate automated medication cabinets in terms of their effect on medication errors, financial savings, productivity improvement and workforce efficiencies.

I refer the Member to the answer to question S5W-26524 on 10 December 2019. All answers to written parliamentary questions are available on the Parliament's website, the search facility for which can be found at: http://www.parliament.scot/parliamentarybusiness/28877.aspx

Work undertaken by the Scottish Government in relation to the contribution of Physician Associates (PA) and Physician Associates (Anaesthesia) (PAA) has focused primarily on gathering information about their use in Scotland and assessing the risks presented by their scope of practice. The Chief Nursing Officer’s Transforming Roles programme has established a short life working group to provide a framework of professional governance to support the development of these roles in the delivery of safe and effective care in Scotland.

Ministers of the devolved administrations wrote to the UK Government in September 2015 in agreement that, in the interests of safety, professional accountability and to maximise the utility of these roles through supplementary and independent prescribing, PAs (and PAAs) should be subject to statutory regulation. It was agreed in the summer of 2019 that the General Medical Council (GMC) should assume this responsibility. A project planning board has recently been established by the GMC to develop the regulatory framework for PAs and PAAs, representation on which includes the four administrations, medical Royal Colleges, deaneries, professional associations and other key stakeholders.